Background {#s1}
==========

*Salmonella enterica* is one of the most important causes of gastrointestinal infection in humans, being the great majority of infections related to the consumption of poultry meat and eggs (Foley and Lynne, [@B14]; EFSA/ECDC, [@B11]).

In animals, infections caused by serotype Enteritidis are rarely responsible for severe disease with animals frequently becoming asymptomatic carriers, except in the case of young chicks and poults, where outbreaks exhibiting clinical disease are often accompanied by high mortality rates (Foley et al., [@B15], [@B13]). Indeed, *S. enterica* subsp. *enterica* serovar Enteritidis (*S*. Enteritidis) has been responsible for severe disease in industrial poultry farming facilities worldwide, posing a potential hazard for public health (Lutful Kabir, [@B26]).

In order to be infectious, *Salmonella* needs to adapt to different niches and conditions, where virulence and heavy-metal-tolerance factors play an important role, through co-selection events and the formation of pathogenicity islands, respectively (Hensel, [@B18]; Medardus et al., [@B28]). Furthermore, antibiotic resistance determinants can also facilitate their survival, with ubiquitous chromosomally encoded efflux mechanisms, playing an important role in both intrinsic, and acquired multidrug resistance. Other resistance mechanisms, such as changes in the membrane permeability, enzymatic modification, and target alterations may increase the levels of bacterial resistance, contributing to the success of the infection (Poole, [@B31]; Delmar et al., [@B9]; Li et al., [@B24]).

Both antibiotic susceptibility determination and serotyping constitute very useful tools for the epidemiologic classification of *S. enterica* isolates. Indeed, in *S. enterica*, the resistance rates fluctuate according to the serotype and with the antibiotic (Clemente et al., [@B7]). Classically, serotyping is based on the antigenic reactivity of lipolysaccharide (O antigen) and flagellar proteins (H antigen), followed by a designation using names or formulas (Grimont and Weill, [@B17]). In this study, we aimed to analyze the genome of a *S*. Enteritidis isolate responsible for omphalitis in chicks, exploring the molecular features associated with antibiotic resistance and pathogenicity, as well as the ability to spread the respective determinants.

Methods {#s2}
=======

Bacterial isolate, antibiotic susceptibility testing, and serotyping
--------------------------------------------------------------------

The isolate (LV60) was recovered from a sample collected from the yolk sac of a chick with omphalitis, under the scope of the "*Salmonella* National Control Programme in food-producing animals and food of animal origin for bacteriological diagnosis, serotype identification and antibiotic susceptibility testing." The guidelines of the Commission Decision (CD), 2007/407/EC were followed. LV60 was tested for its antimicrobial resistance through the determination of minimum inhibitory concentrations (MICs) using the agar dilution method, as previously described (Clemente et al., [@B6]) and according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines (<http://www.eucast.org/>). Briefly, a panel of 11 antibiotic compounds was tested in a 2-fold concentration series over the following ranges: ampicillin and tetracycline (0.5--64 μg/mL), gentamicin and trimethoprim (0.25--32 μg/mL), ciprofloxacin (0.008--8 μg/mL), cefotaxime (0.06--8 μg/mL), nalidixic acid and streptomycin (2--512 μg/mL), chloramphenicol (2--256 μg/mL), florfenicol (1--128 μg/mL) and sulphamethoxazole (8--1024 μg/mL). The epidemiological cut-off values recommended by EUCAST to *Salmonella* spp. were used for the interpretation of susceptibility testing results. Quality control was performed using the *Escherichia coli* ATCC 25922 strain. LV60 isolate was then serotyped by the slide agglutination method for its O and H antigens using the method of Kauffman-White scheme (Grimont and Weill, [@B17]).

Whole genome sequencing (WGS), assembly, and annotation
-------------------------------------------------------

Genomic DNA was extracted using DNeasy Blood and Tissue Kit (Qiagen), and DNA quantification was performed by Qubit Fluorometric Quantitation (Life Technologies), according to with the manufacturer\'s instructions. The genome was sequenced using a double strategy of 454 (Roche) and MiSeq (Illumina) sequencing.

Five hundred nanograms of bacterial DNA were fragmented by nebulization, followed by adaptor ligation to create double stranded DNA libraries and sequenced on a 454 GS FLX Titanium according to the standard manufacturer\'s instructions (Roche-454 Life Sciences). The second genome library was prepared from 1 ng of genomic DNA using the Nextera XT DNA Sample Preparation Kit (Illumina) and sequenced on the Illumina MiSeq sequencer (Illumina) using paired-end 2 × 150 bp reads.

First quality evaluation of raw read sequences and their corresponding quality values were assigned by the FastQC software. Reads were then trimmed and filtered according to quality criteria, and *de novo* assembled with Ray, version 2.3.1 (Boisvert et al., [@B4]). Contigs were searched for identity through blastn (<http://blast.ncbi.nlm.nih.gov/Blast.cgi>) against the nr/nt NCBI database to identify the closest bacterial genome and/or plasmid. Therefore, LV60 genome was mapped against the bacterial genome of *S*. Enteritidis strain p125109 and its plasmid (NC_011294 and HG970000, respectively) using GS Mapper version 2.9 (Roche). Additionally SNV (single nucleotide variants) and structural variants were also detected with the GS Mapper (Roche, version 2.9).

Structural and functional annotation was performed using PGP (Prokaryotic Genome Prediction) (Egas et al., [@B10]), an in-house developed pipeline. Taxonomy identification was performed by BLASTP search against the NCBI GenBank non-redundant (nr) database of the 16 s rRNA sequence gene, identified in the previous step and confirmed using RNAmmer v1.2 (Lagesen et al., [@B21]).

The final data was submitted in the DDBJ/EMBL/GenBank databases, using the Sequin software tool (<http://www.ncbi.nlm.nih.gov/Sequin/>). This dataset, which includes files in Genbank (LIHI01.1.gbff.gz), Fasta (LIHI01.1.fsa_nt.gz), and ASN.1 (LIHI01.1.bbs.gz) formats, can be accessed and/or reused at <http://www.ncbi.nlm.nih.gov/nuccore/LIHI00000000>.

*In silico* analyses
--------------------

CLC genomics workbench 8.0 (QIAGEN, Aarhus), PathogenFinder 1.1, ResFinder 2.1, PlasmidFinder 1.3, and MLST 1.8 (MultiLocus Sequence Typing) were used to estimate the number of pathogenicity determinants, acquired antibiotic resistance genes, plasmids and the MLST using the *S*. Enteritidis genome (Larsen et al., [@B22]; Zankari et al., [@B33]; Cosentino et al., [@B8]; Carattoli et al., [@B5]). SeqSero tool was used for *Salmonella* serotyping by whole genome sequencing (Zhang et al., [@B34]).

PHAST search web tool was applied to detect, identify and annotate prophage sequences (Zhou et al., [@B35]). ISsaga was used for the high throughput identification and semiautomatic annotation of insertion sequences in the genome (Varani et al., [@B32]). The presence of molecular determinants of antimicrobial resistance was predicted based on homology and SNP models using the Comprehensive Antibiotic Resistance Database (CARD; <https://card.mcmaster.ca/analyze/rgi>), through Resistance Gene Identifier software (RGI; McArthur et al., [@B27]).

Results {#s3}
=======

LV60 isolate was serotyped as *S*. Enteritidis, using the method of Kauffman-White scheme, and found to be wild-type to all the antibiotics tested, except tetracycline.

The *de novo* assembly yielded 4.977 Mbp distributed in 83 contigs (largest contig with 970,921 bp) with a N50 of 491,005 bp. Overall, the structural and functional annotation with PGP detected 97 tRNA genes, 7 rRNA genes and identified 4656 mRNA genes.

From mapping against the bacterial genome of *S*. Enteritidis strain p125109, the main difference between the two genomes was the absence of the O-antigen polymerase gene *wzy* in the LV60 isolate, which in *S*. Enteritidis is located outside the O antigen gene cluster (Liu et al., [@B25]). The coding sequence of *wzy* gene was searched against the assembled genome using blastn, confirming its absence. The flanking regions of *wzy* gene, which coded for a disrupted membrane and a hypothetical protein, were also absent. The *wzy* gene is involved in the Wzx/Wzy-dependent pathway, which constitutes the predominant pathway for O-antigen production in Gram-negative bacteria, specifically in *Salmonella* (Hong et al., [@B19]).

However, in this study, the absence of the *wzy* gene did not compromised the use of a high-throughput genome sequencing serotype determination method (Zhang et al., [@B34]), which corroborated the result obtained by the gold standard method. Indeed, this method, based on the detection of O and H antigens encoding genes, predicted an antigenic profile 9:g,m:- based on the O-9,46 *wba*V gene, which encodes to the O-antigen tyvelosyl transferase. Furthermore, the *S*. Enteritidis serotype was confirmed by the presence of *sdf* gene (*Salmonella* difference fragment virulence gene), a characteristic marker of commonly circulating *S. enterica* serovar Enteritidis (Agron et al., [@B1]).

Sixty-one SNVs were detected between LV60 and the *S*. Enteritidis strain p125109. The SNVs that resulted in amino acid substitutions are represented in Table [1](#T1){ref-type="table"}. *In silico* analysis with ResFinder tool did not reveal the presence of any acquired antibiotic resistance genes (90% identity and 40% minimum length) or plasmids (95% identity). However, the RGI analysis, using the *perfect algorithm*, showed the presence of a *Salmonella*-specific MerR-like gold (Au) sensor- GolS---involved in Au resistance (Pontel et al., [@B30]). This constitutes a matter of concern since antibacterial biocides and metals can contribute to the development and maintenance of antibiotic resistance in bacterial communities through mechanisms of cross- or co-resistance (Baker-Austin et al., [@B3]; Lemire et al., [@B23]; Pal et al., [@B29]).

###### 

**Single nucleotide variants that represent amino acid substitutions in *S*. Enteritidis LV60 using *S*. Enteritidis strain p125109 as the reference genome**.

  **Reference Position**   **Reference**   **Allele**   **Gene (Product)**                                                       **Amino acid change**   **Coverage**
  ------------------------ --------------- ------------ ------------------------------------------------------------------------ ----------------------- --------------
  40158                    C               T            SEN_RS00180 (arylsulfatase)                                              Pro92Ser                155
  55278                    C               A            *ileS* (isoleucine-tRNA ligase)                                          Ala557Glu               144
  93979                    G               A            SEN_RS00415 (hypothetical protein)                                       Ala96Thr                127
  156264                   G               A            SEN_RS00685 (peptidase M23)                                              Gly299Asp               123
  353437                   T               C            SEN_RS01600 (isopropylmalate isomerase)                                  Val454Ala               119
  357149                   A               T            SEN_RS01625 (hypothetical protein)                                       Leu1Met                 177
  401018                   C               A            *prpE* (acetyl-CoA synthetase)                                           Arg9Ser                 132
  411602                   T               G            SEN_RS01845 (hypothetical protein)                                       Trp209Gly               58
  561577                   T               C            SEN_RS02560 (MFS transporter)                                            Ser333Pro               68
  659902                   T               G            *dpiB* (sensor histidine kinase)                                         Tyr3Asp                 52
  988620                   G               C            SEN_RS04610 (hypothetical protein)                                       Ala89Pro                130
  1044895                  G               T            *helD* (DNA helicase IV)/Mobile element                                  Ala204Ser               75
  1156702                  G               C            *sirA* (virulence gene transcriptional regulator)                        Val181Leu               112
  1325689                  A               G            SEN_RS06450 (hydrogenase-1 operon protein HyaF)                          Tyr209His               93
  1427037                  T               A            SEN_RS06930 (diguanylate phosphodiesterase)                              Asp16Glu                92
  1787654                  A               G            SEN_RS08735 (transporter)                                                Arg348Gly               79
  1807289                  G               A            SEN_RS08820 (lipoprotein)                                                Ala14Val                79
  1931818                  C               T            SEN_RS09505 (NAD-dependent deacetylase)                                  Met37Ile                82
  2115337                  C               T            SEN_RS10585 (cobalamin biosynthesis protein CbiB)                        Gly167Ser               104
  2419980                  G               A            SEN_RS11950 (NADH:ubiquinone oxidoreductase subunit M)                   Leu474Phe               130
  2426844                  A               G            SEN_RS11980 (NADH dehydrogenase subunit G)                               Val610Ala               125
  2463887                  T               C            SEN_RS12170 (amino acid transporter)                                     Ile452Val               34
  2647060                  G               A            SEN_RS12985 (outer membrane protein RatA)                                Pro459Ser               108
  2647626                  G               T            SEN_RS12985 (outer membrane protein RatA)                                Ala270Glu               111
  2672592                  A               C            SEN_RS13070 (hypothetical protein)                                       Ile313Ser               61
  2956057                  C               A            SEN_RS14420 (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase)   Arg53Leu                123
  3185834                  C               A            SEN_RS15495 (D-mannonate oxidoreductase)                                 Asn151Lys               81
  3659470                  G               T            SEN_RS17815 (membrane protein)                                           Gln71Lys                122
  3802073                  G               A            *coaD* (phosphopantetheine adenylyltransferase)                          Val116Ile               127
  4051393                  T               C            SEN_RS19620 (DNase TatD)                                                 Ser141Pro               150
  4059155                  G               A            *fadB* (3-ketoacyl-CoA thiolase)                                         Ala395Val               84
  4348398                  A               G            SEN_RS20980 (membrane protein)/ Salmonella Pathogenicity Island 4        Asn2902Asp              158
  4402123                  C               T            SEN_RS21190 (sugar:sodium symporter)                                     Ala350Val               77
  4476625                  T               C            SEN_RS21580 (hypothetical protein)                                       Lys76Glu                170
  4555382                  C               T            SEN_RS21985 (DNA polymerase III subunit chi)                             Asp10Asn                110

Furthermore, the RGI strict algorithm, which detects previously unknown variants of known antimicrobial resistance genes, identified 52 genes involved in efflux, transport, and permeability, which might justify the low-level tetracycline resistance identified by phenotypic methods (Table [2](#T2){ref-type="table"}). Resistance to additional classes of antibiotics such as fluoroquinolones, aminoglycosides, and chloramphenicol were bioinformatically predicted. Indeed, efflux pumps are often associated with discrete decreases in antibiotic susceptibility that may not necessarily reflect an alteration in interpretation categories (Fernández and Hancock, [@B12]). Genes responsible for the intrinsic resistance to benzylpenicillin, glycopeptides, macrolides, and rifampicin were also detected.

###### 

**Perfect and strict best hit results, by predicted gene, obtained using the Resistance Gene Identifier (RGI)**.

  **Predicted gene**   ***e*-value**   **Identity (%)**   **Contig**   **Average coverage**   **Start**   **Stop**   **RGI Cut-off**   **RGI Protein Model_type**   **Antibiotic Resistance Ontology (ARO) category**
  -------------------- --------------- ------------------ ------------ ---------------------- ----------- ---------- ----------------- ---------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *golS*               1.41E--108      100                4            147.97                 80575       81039      Perfect           homolog                      efflux pump conferring AR; chloramphenicol RG; beta-lactam RG; gene modulating antibiotic efflux
  *acrF*               0               99                 4            147.97                 73608       76775      Strict            homolog                      efflux pump conferring AR; beta-lactam RG; fluoroquinolone RG
  *sdiA*               0               99                 2            127.7                  1179091     1179813    Strict            homolog                      chloramphenicol RG; gene modulating antibiotic efflux; fluoroquinolone RG; efflux pump conferring AR; tetracycline RG; rifampin RG; beta-lactam RG
  *crp*                1.30E--151      99                 7            160.37                 388833      389465     Strict            homolog                      efflux pump conferring AR; macrolide RG; beta-lactam RG; gene modulating antibiotic efflux; fluoroquinolone RG
  *mdsA*               0               98                 4            147.97                 76772       77977      Strict            homolog                      efflux pump conferring AR; chloramphenicol RG; beta-lactam RG
  *mdsC*               0               98                 4            147.97                 72134       73624      Strict            homolog                      efflux pump conferring AR; chloramphenicol RG; beta-lactam RG
  *aac(6\')-Iy*        2.36E--101      97                 2            127.7                  808040      808477     Strict            homolog                      antibiotic inactivation enzyme; aminoglycoside RG
  *cpxR*               1.24E--160      97                 3            152.34                 67603       68301      Strict            homolog                      efflux pump conferring AR; aminocoumarin RG; aminoglycoside RG; gene modulating antibiotic efflux
  *bacA*               0               97                 14           155.64                 142061      142882     Strict            homolog                      peptide AR gene; gene conferring AR via molecular bypass
  *cpxA*               0               96                 3            152.34                 66233       67606      Strict            homolog                      efflux pump conferring AR; aminocoumarin RG; aminoglycoside RG; gene modulating antibiotic efflux
  *baeR*               5.11E--165      96                 2            127.7                  107261      107983     Strict            homolog                      efflux pump conferring AR; aminocoumarin RG; aminoglycoside RG; gene modulating antibiotic efflux
  *emrY*               0               95                 8            158.13                 93935       95473      Strict            homolog                      efflux pump conferring AR; tetracycline RG
  *marA*               1.35E--82       95                 2            127.7                  702301      702690     Strict            homolog                      chloramphenicol RG; gene modulating antibiotic efflux; gene modulating permeability to antibiotic; fluoroquinolone RG; efflux pump conferring AR; tetracycline RG; rifampin RG; beta-lactam RG
  *H-NS*               9.89E--75       94                 2            127.7                  965098      965511     Strict            homolog                      gene modulating antibiotic efflux; macrolide RG; fluoroquinolone RG; efflux pump conferring AR; tetracycline RG; beta-lactam RG
  *mexD*               0               94                 5            135.43                 37513       40626      Strict            homolog                      chloramphenicol RG; trimethoprim RG; macrolide RG; fluoroquinolone RG; efflux pump conferring AR; beta-lactam RG
  *phoP*               6.18E--151      93                 2            127.7                  417112      417786     Strict            homolog                      efflux pump conferring AR; polymyxin RG; macrolide RG; gene modulating antibiotic efflux; gene altering cell wall charge conferring AR
  *emrR*               7.58E--115      93                 8            158.13                 92089       92619      Strict            homolog                      efflux pump conferring AR; gene modulating antibiotic efflux; fluoroquinolone RG
  *mexD*               0               93                 4            147.97                 209028      212177     Strict            homolog                      chloramphenicol RG; trimethoprim RG; macrolide RG; fluoroquinolone RG; efflux pump conferring AR; beta-lactam RG
  *mdtH*               0               92                 2            127.7                  349496      350704     Strict            homolog                      efflux pump conferring AR
  *mdtK*               0               92                 2            127.7                  607306      608679     Strict            homolog                      efflux pump conferring AR; fluoroquinolone RG
  *mexN*               0               92                 2            127.7                  113873      116995     Strict            homolog                      efflux pump conferring AR; chloramphenicol RG
  *mexN*               0               91                 2            127.7                  110792      113872     Strict            homolog                      efflux pump conferring AR; chloramphenicol RG
  *emrD*               0               90                 7            160.37                 11534       12718      Strict            homolog                      efflux pump conferring AR
  *mdtG*               0               90                 2            127.7                  339682      340896     Strict            homolog                      efflux pump conferring AR
  *pmrA*               1.77E--143      90                 9            160.96                 119082      119750     Strict            homolog                      polymyxin RG; gene altering cell wall charge conferring AR
  *emrA*               0               89                 8            158.13                 92719       93918      Strict            homolog                      efflux pump conferring AR; fluoroquinolone RG
  *pmrE*               0               89                 2            127.7                  174573      175739     Strict            homolog                      polymyxin RG; gene altering cell wall charge conferring AR
  *baeS*               0               89                 2            127.7                  107980      109383     Strict            homolog                      efflux pump conferring AR; aminocoumarin RG; aminoglycoside RG; gene modulating antibiotic efflux
  *tolC*               0               89                 14           155.64                 163404      164879     Strict            homolog                      chloramphenicol RG; macrolide RG; fluoroquinolone RG; efflux pump conferring AR; aminocoumarin RG; tetracycline RG; rifampin RG; beta-lactam RG
  *acrE*               0               88                 1            155.02                 4223        5380       Strict            homolog                      efflux pump conferring AR; beta-lactam RG; fluoroquinolone RG
  *mexD*               0               88                 1            155.02                 1098        4211       Strict            homolog                      chloramphenicol RG; trimethoprim RG; macrolide RG; fluoroquinolone RG; efflux pump conferring AR; beta-lactam RG
  *mdfA*               0               87                 13           131.07                 105101      106333     Strict            homolog                      efflux pump conferring AR
  *pmrF*               0               87                 5            135.43                 231615      232598     Strict            homolog                      polymyxin RG; gene altering cell wall charge conferring AR
  *mdtM*               0               86                 11           163.1                  148308      149549     Strict            homolog                      efflux pump conferring AR
  *ramA*               1.93E--71       86                 4            147.97                 311233      311622     Strict            homolog                      chloramphenicol RG; gene modulating antibiotic efflux; gene modulating permeability to antibiotic; fluoroquinolone RG; efflux pump conferring AR; tetracycline RG; rifampin RG; beta-lactam RG
  *mdtD*               0               86                 2            127.7                  109383      110795     Strict            homolog                      efflux pump conferring AR
  *acrA*               0               85                 4            147.97                 212200      213393     Strict            homolog                      chloramphenicol RG; fluoroquinolone RG; efflux pump conferring AR; tetracycline RG; rifampin RG; beta-lactam RG
  *phoQ*               0               85                 2            127.7                  415649      417112     Strict            homolog                      efflux pump conferring AR; polymyxin RG; macrolide RG; gene modulating antibiotic efflux; gene altering cell wall charge conferring AR
  *pmrB*               0               85                 9            160.96                 118002      119081     Strict            homolog                      polymyxin RG; gene altering cell wall charge conferring AR
  *mdtA*               0               82                 2            127.7                  116995      118332     Strict            homolog                      efflux pump conferring AR; aminocoumarin RG
  *pmrC*               0               82                 9            160.96                 119747      121390     Strict            homolog                      polymyxin RG; gene altering cell wall charge conferring AR
  *acrR*               1.83E--124      82                 4            147.97                 213535      214188     Strict            variant                      chloramphenicol RG; gene modulating antibiotic efflux; fluoroquinolone RG; efflux pump conferring AR; antibiotic resistant gene variant or mutant; tetracycline RG; rifampin RG; beta-lactam RG
  *robA*               0               81                 11           163.1                  77518       78387      Strict            homolog                      chloramphenicol RG; gene modulating antibiotic efflux; fluoroquinolone RG; efflux pump conferring AR; tetracycline RG; rifampin RG; beta-lactam RG
  *arnA*               0               79                 5            135.43                 229636      231618     Strict            homolog                      polymyxin RG; gene altering cell wall charge conferring AR
  *mdtL*               0               77                 16           156.65                 44691       45878      Strict            homolog                      efflux pump conferring AR
  *rosB*               0               74                 4            147.97                 230248      231924     Strict            homolog                      polymyxin RG
  *rosA*               0               71                 4            147.97                 232128      233348     Strict            homolog                      efflux pump conferring AR; polymyxin RG
  *rpoB*               0               58                 19           154.2                  4220        8248       Strict            variant                      rifampin RG; antibiotic resistant gene variant or mutant
  *katG*               0               56                 3            152.34                 121560      123740     Strict            variant                      antibiotic resistant gene variant or mutant; isoniazid RG
  *gyrB*               0               55                 16           156.65                 54369       56783      Strict            homolog                      aminocoumarin RG; antibiotic resistant gene variant or mutant
  *macB*               0               50                 13           131.07                 143618      145564     Strict            homolog                      efflux pump conferring AR; macrolide RG
  *vanG*               8.15E--81       38                 4            147.97                 113335      114447     Strict            homolog                      glycopeptide RG; AR gene cluster, cassette, or operon; gene conferring AR via molecular bypass
  *macA*               2.30E--51       35                 13           131.07                 142503      143621     Strict            homolog                      efflux pump conferring AR; macrolide RG

*RG, resistance gene; AR, antibiotic resistance*.

The total number of pathogenicity determinants present in the genome of *S*. Enteritidis LV60, matching 1164 pathogenic families, showed a 94.1% certainty of the isolate being a human pathogen. Here we highlight the presence of *Salmonella* Pathogenicity Island 4, which usually encodes a non-fimbrial adhesion and the cognate type 1 secretion system (Gerlach et al., [@B16]).

The use of complementary web tools assigned this isolate to ST11, which according with MLST data (<http://mlst.warwick.ac.uk/>) is commonly found among CTX-M-14 and CTX-M-15-producing *S*. Enteritidis human isolates (Kim et al., [@B20]; Bado et al., [@B2]). In this study, the identification of ST11 in an isolate of animal origin, together with other pathogenicity determinants may suggest its zoonotic potential.

We also identified 6 prophage regions, among which three were incomplete and three were intact. The last included prophage regions reaching the lengths of 64.3, 49.2, and 31.7 Kb, and encoding 42, 78, and 66 DNA coding sequences, respectively.

Overall, 33 different IS were detected within the genome, which were distributed as follows: 27.03% of IS*3* family, 18.92% of IS*256* family, 13.51% of IS unclassified elements, 10.81% of IS*200*/IS*605* complex, and of IS*L3* family, 8.11% of IS*481* family, 5.41% of IS*630* family, and 2.7% of IS*1* and IS*110* families. All identified structures (pathogenicity island, prophages, ISs) constitute a multiplicity of pathogenicity factors in LV60 *S*. Enteritidis isolate and contribute for the fitness of the isolate in different environments; its presence may also suggest the possibility of acquisition of other factors by different mechanisms, including resistance genes e.g., by horizontal gene transfer, contributing to its biological diversity and genetic evolution.

Conclusion {#s4}
==========

The detection of an avian *S*. Enteritidis isolate harboring multiple efflux pumps, pathogenicity factors, a variety of mobile genetic elements and heavy-metal-tolerance genes raises concerns regarding the dissemination of infection in birds and potential risk of zoonotic transmission.

This study demonstrated the added value of WGS as a routine tool for surveillance programs directed to food-producing animals, which might complement sanitary measures, essential to prevent the spread of *Salmonella* infections among animals. It also proved to have an added value as a complementary typing method. Moreover, the simultaneous detection of putative Au resistance, intrinsic antibiotic resistant genes, and mobile genetic elements, underline this method as a helpful resource to follow the spread and evolution of antibiotic resistance in this species by genomic comparison studies.
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